Granules India Limited (NSE:GRANULES)
439.55
-10.45 (-2.32%)
Aug 8, 2025, 3:29 PM IST
Accolade Market Cap
Granules India has a market cap or net worth of 106.68 billion as of August 8, 2025. Its market cap has decreased by -18.12% in one year.
Market Cap
106.68B
Enterprise Value
116.54B
Revenue
44.82B
Ranking
n/a
PE Ratio
21.27
Stock Price
$439.55
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 106.68B, an increase of 65,066.92%. That is a compound annual growth rate of 33.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 106.68B | -25.61% |
Dec 31, 2024 | 143.40B | 45.94% |
Dec 29, 2023 | 98.26B | 27.40% |
Dec 30, 2022 | 77.13B | -7.49% |
Dec 31, 2021 | 83.37B | -4.42% |
Dec 31, 2020 | 87.22B | 178.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,827.42B |
Divi's Laboratories | 1,628.25B |
Cipla | 1,200.88B |
Mankind Pharma | 1,055.02B |
Apollo Hospitals Enterprise | 1,033.74B |
Zydus Lifesciences | 938.51B |
Fortis Healthcare | 647.87B |
Aurobindo Pharma | 622.79B |